report

From Dominance to Compliance

Last Tuesday saw Binance settle its long-running legal disputes with several U.S. government agencies, including the Department of Justice (DoJ), the Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN), the Office of Foreign Assets Control (OFAC), and the U.S. Commodity Futures Trading Commission (CFTC). However, they failed to reach an agreement with the Securities and Exchange Commission (SEC) regarding their pending charges. As part of the settlement, Binance has agreed to pay an eye-popping fine of $4.3 billion. Furthermore, Changpeng Zhao (CZ), the CEO of Binance, will step down

HealthCare AI: The Unavoidable Revolution in Modern Medicine

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

The Tightrope of Regulation

In a significant move at the recent G20 meeting in India, the International Monetary Fund (IMF) and the Financial Stability Board (FSB) released a joint paper outlining a framework for the global regulation of cryptocurrencies. While the proposals mostly tread familiar territory, what’s new is their conviction in crypto’s unstoppable growth and success. A flurry of optimism greeted the G20’s endorsement of the report because it advocates that countries don’t ban crypto. Hidden in its text, however, are some worrying signs. For example, on the first page, they state, “Widespread

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Swiss WEB3FEST 2023: The Convergence of Web3 Innovation and Collaboration

The Global Web3 Ecosystem is set to unite under the banner of "Switzerland United", an 11-day extravaganza, from September 7th-17th 2023, that combines the forces of the NFT Fest Lugano, NFT Lakeside Unconference and the Swiss WEB3FEST. Key Highlights The Swiss WEB3FEST will be the center of Web3 innovation and collaboration, with over 150 Preeminent speakers, 50+ exhibitors and 80+ captivating topics and side events The Swiss WEB3FEST is the Ecosystem Festival of Crypto Valley and Crypto Oasis and is Co-Hosted by Dfinity aka The Internet Computer The Conference is

Dynamic Coalition on Blockchain Assurance and Standardization (DC-BAS)

Introduction Blockchains are a promising technology with the potential to transform many industries. However, there are still challenges that need to be addressed before blockchain solutions can reach their full potential. Blockchains are important because they can be used to create secure and transparent systems. For example, blockchains can streamline the delivery of public services to underserved communities and populations, strengthen transparency and integrity for public services, and ultimately build trust amongst all stakeholders. As blockchain technology continues to develop, it is likely to have a major impact on the

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

SaaS Inclusology Releases New 2.0 Platform and Proves to Help Companies Achieve DEI (Diversity, Equity, and Inclusion) Goals in Accelerated Timeline.

June 2023 - Inclusology, is a powerful all in one DEI management SaaS platform designed to help companies reduce bias in the workplace and increase employee retention. Last week, the platform released its new version after completing beta testing among 16 companies and thousands of employees across startups, nonprofits, Fortune 500 and 1000 companies etc. “We are so proud to see Inclusology’s work having a positive impact on DEI at a global level in every sized company,” says CEO Dr. Cheryl Ingram. “We’ve tested our software in a number of

Tokenovate and GMEX ZERO13 Enable Execution of World’s First Smart Legal Contract for Voluntary Carbon Credit Derivatives Trades using ISDA Definitions.

BSV Blockchain based smart legal contract powers successful trade execution and settlement. London, May 31, 2023 - Tokenovate, a financial services company providing distributed financial market infrastructure (dFMI) enabling programmatic lifecycle event management of the pre-trade to post-trade workflow for OTC and Exchange traded derivatives, and ZERO13, a GMEX Group initiative, providing a digital climate fintech aggregation ecosystem announce the successful execution of the world's first smart legal contract for voluntary carbon credit (VCC) derivatives trades referencing the 2022 ISDA (The International Swaps and Derivatives Association) Verified Carbon Credit Transactions

Crypto Oasis Ecosystem Report 2023: Identifies 1,800+ Organisations in the Thriving UAE Web3 Space

Over 8,650 individuals currently contribute to the thriving Crypto, Blockchain, Metaverse, and Web3 Ecosystem of the UAE Highlights Get an in-depth look at the world's fastest growing Blockchain ecosystem in the newly launched spring edition of the report at the Dubai FinTech Summit 2023 The report provides a comprehensive breakdown of the ecosystem's main elements, including Governments & Associations, Startups & Projects, Investors & Collectors, Service Providers, Corporates, and Education & Research Of the total number of organisations, native ones make up 70.24% (1,270 organisations), while non-native ones account for

Dubai Fintech Summit Welcomes Crypto Oasis as Web3 Ecosystem Partner

4th May 2023, Dubai, UAE: Dubai Fintech Summit is proud to announce its partnership with Crypto Oasis as the official Web3 Ecosystem partner for the upcoming summit, which will take place on 8th and 9th May 2023. The Crypto Oasis is a MENA focused Blockchain Ecosystem headquartered in Dubai, UAE. The core elements needed for its growth are Talent, Capital, and Infrastructure. The Ecosystems stakeholders include Investors & Collectors, Start-Ups & Projects, Corporates, Science & Research Institutions, Service Providers and Government Entities & Associations. Crypto Oasis’ vision is to be